PMV Pharmaceuticals, Inc. — Director's Dealing 2022

Nov 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2022-11-04

Reporting Person: Gallagher Carol Giltner (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-04	Stock Option (right to buy)	$11.28	A	39000	Acquired	2032-11-03	Common Stock (39000)	Direct
2022-11-05	Stock Option (right to buy)	$11.28	G	39000	Disposed	2032-11-03	Common Stock (39000)	Direct
2022-11-05	Stock Option (right to buy)	$11.28	G	39000	Acquired	2032-11-03	Common Stock (39000)	Indirect

Footnotes

F1: Shares subject to the option vest in 36 equal, monthly installments beginning on December 4, 2022.

F2: The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee.